Synergistic Effects of the in cis T251I and P587L Mitochondrial DNA Polymerase γ Disease Mutations*

Human mitochondrial DNA (mtDNA) polymerase γ (Pol γ) is the only polymerase known to replicate the mitochondrial genome. The Pol γ holoenzyme consists of the p140 catalytic subunit (POLG) and the p55 homodimeric accessory subunit (POLG2), which enhances binding of Pol γ to DNA and promotes processivity of the holoenzyme. Mutations within POLG impede maintenance of mtDNA and cause mitochondrial diseases. Two common POLG mutations usually found in cis in patients primarily with progressive external ophthalmoplegia generate T251I and P587L amino acid substitutions. To determine whether T251I or P587L is the primary pathogenic allele or whether both substitutions are required to cause disease, we overproduced and purified WT, T251I, P587L, and T251I + P587L double variant forms of recombinant Pol γ. Biochemical characterization of these variants revealed impaired DNA binding affinity, reduced thermostability, diminished exonuclease activity, defective catalytic activity, and compromised DNA processivity, even in the presence of the p55 accessory subunit. However, physical association with p55 was unperturbed, suggesting intersubunit affinities similar to WT. Notably, although the single mutants were similarly impaired, a dramatic synergistic effect was found for the double mutant across all parameters. In conclusion, our analyses suggest that individually both T251I and P587L substitutions functionally impair Pol γ, with greater pathogenicity predicted for the single P587L variant. Combining T251I and P587L induces extreme thermal lability and leads to synergistic nucleotide and DNA binding defects, which severely impair catalytic activity and correlate with presentation of disease in patients.

[1]  K. DeBalsi,et al.  Role of the mitochondrial DNA replication machinery in mitochondrial DNA mutagenesis, aging and age-related diseases , 2017, Ageing Research Reviews.

[2]  M. Aschner,et al.  Mitochondrial Redox Dysfunction and Environmental Exposures. , 2015, Antioxidants & redox signaling.

[3]  Smita S. Patel,et al.  Structural basis for processivity and antiviral drug toxicity in human mitochondrial DNA replicase , 2015, The EMBO journal.

[4]  Kathie Y Sun,et al.  POLG2 disease variants: analyses reveal a dominant negative heterodimer, altered mitochondrial localization and impaired respiratory capacity. , 2015, Human molecular genetics.

[5]  C. Gustafsson,et al.  The exonuclease activity of DNA polymerase γ is required for ligation during mitochondrial DNA replication , 2015, Nature Communications.

[6]  M. Elia,et al.  The in cis T251I and P587L POLG1 base changes: Description of a new family and literature review , 2015, Neuromuscular Disorders.

[7]  Jeffrey D. Stumpf,et al.  MMS Exposure Promotes Increased MtDNA Mutagenesis in the Presence of Replication-Defective Disease-Associated DNA Polymerase γ Variants , 2014, PLoS genetics.

[8]  Michael E. Watson,et al.  Fatal human herpesvirus 6-associated encephalitis in two boys with underlying POLG mitochondrial disorders. , 2014, Pediatric neurology.

[9]  Gregory A. Farnum,et al.  Mapping 136 pathogenic mutations into functional modules in human DNA polymerase γ establishes predictive genotype-phenotype correlations for the complete spectrum of POLG syndromes. , 2014, Biochimica et biophysica acta.

[10]  W. Copeland Defects of Mitochondrial DNA Replication , 2014, Journal of child neurology.

[11]  C. Richelme,et al.  Quantitative multiplex PCR of short fluorescent fragments for the detection of large intragenic POLG rearrangements in a large French cohort , 2013, European Journal of Human Genetics.

[12]  Michael O. Hengartner,et al.  Mitochondria as a Target of Environmental Toxicants , 2013, Toxicological sciences : an official journal of the Society of Toxicology.

[13]  I. Minko,et al.  Translesion Synthesis Past Acrolein-derived DNA Adducts by Human Mitochondrial DNA Polymerase γ* , 2013, The Journal of Biological Chemistry.

[14]  R. Kasiviswanathan,et al.  Biochemical analysis of the G517V POLG variant reveals wild-type like activity. , 2011, Mitochondrion.

[15]  W. Craigen,et al.  Mitochondrial DNA polymerase γ mutations: an ever expanding molecular and clinical spectrum , 2011, Journal of Medical Genetics.

[16]  L. Wong,et al.  Biochemical analysis of human POLG2 variants associated with mitochondrial disease. , 2011, Human molecular genetics.

[17]  R. Fontana,et al.  Polymerase γ Gene POLG determines the risk of sodium valproate‐induced liver toxicity , 2010, Hepatology.

[18]  F. Foury,et al.  A cluster of pathogenic mutations in the 3'-5' exonuclease domain of DNA polymerase gamma defines a novel module coupling DNA synthesis and degradation. , 2010, Human molecular genetics.

[19]  R. Kasiviswanathan,et al.  Purification and functional characterization of human mitochondrial DNA polymerase gamma harboring disease mutations. , 2010, Methods.

[20]  R. Naviaux,et al.  The clinical diagnosis of POLG disease and other mitochondrial DNA depletion disorders. , 2010, Methods.

[21]  R. Saneto,et al.  Sensory ataxic neuropathy with dysarthria and ophthalmoparesis (SANDO) in late life due to compound heterozygous POLG mutations , 2010, Muscle & nerve.

[22]  R. Naviaux,et al.  Polymerase gamma disease through the ages. , 2010, Developmental disabilities research reviews.

[23]  I. Molineux,et al.  A Single Mutation in Human Mitochondrial DNA Polymerase Pol γA Affects Both Polymerization and Proofreading Activities of Only the Holoenzyme* , 2010, The Journal of Biological Chemistry.

[24]  M. Golomb,et al.  Is it ADEM, POLG, or both? , 2010, Archives of neurology.

[25]  R. Kasiviswanathan,et al.  92 Disease mutations in the human mitochondrial DNA polymerase thumb subdomain impart severe defects in mtDNA replication , 2010 .

[26]  Robert W. Taylor,et al.  Mitochondrial DNA mutations and human disease. , 2010, Biochimica et biophysica acta.

[27]  W. Copeland The mitochondrial DNA polymerase in health and disease. , 2010, Sub-cellular biochemistry.

[28]  Jeffrey D. Stumpf,et al.  Mitochondrial DNA replication and disease: insights from DNA polymerase γ mutations , 2010, Cellular and Molecular Life Sciences.

[29]  Y. Yin,et al.  Structural Insight into Processive Human Mitochondrial DNA Synthesis and Disease-Related Polymerase Mutations , 2009, Cell.

[30]  H. Smeets,et al.  The unfolding clinical spectrum of POLG mutations , 2009, Journal of Medical Genetics.

[31]  C. Tzoulis,et al.  Mitochondrial DNA depletion in progressive external ophthalmoplegia caused by POLG1 mutations , 2009, Acta neurologica Scandinavica. Supplementum.

[32]  R. Kasiviswanathan,et al.  Disease Mutations in the Human Mitochondrial DNA Polymerase Thumb Subdomain Impart Severe Defects in Mitochondrial DNA Replication* , 2009, The Journal of Biological Chemistry.

[33]  W. Copeland,et al.  DNA polymerase gamma and mitochondrial disease: understanding the consequence of POLG mutations. , 2009, Biochimica et biophysica acta.

[34]  Christopher M. Bailey,et al.  R964C Mutation of DNA Polymerase γ Imparts Increased Stavudine Toxicity by Decreasing Nucleoside Analog Discrimination and Impairing Polymerase Activity , 2009, Antimicrobial Agents and Chemotherapy.

[35]  B. Debuire,et al.  Relationship between polymerase gamma (POLG) polymorphisms and antiretroviral therapy-induced lipodystrophy in HIV-1 infected patients: a case-control study. , 2009, Current HIV research.

[36]  D. Turnbull,et al.  Novel POLG1 mutations associated with neuromuscular and liver phenotypes in adults and children , 2008, Journal of Medical Genetics.

[37]  J. Ganesh,et al.  Molecular and clinical genetics of mitochondrial diseases due to POLG mutations , 2008, Human mutation.

[38]  N. Ashley,et al.  Depletion of mitochondrial DNA in fibroblast cultures from patients with POLG1 mutations is a consequence of catalytic mutations , 2008, Human molecular genetics.

[39]  V. Ramesh,et al.  Reversible valproate hepatotoxicity due to mutations in mitochondrial DNA polymerase γ (POLG1) , 2008, Archives of Disease in Childhood.

[40]  W. Copeland,et al.  59 Modulation of the W748S mutation in DNA polymerase gamma by the E1143G polymorphism in mitochondrial disorders , 2007 .

[41]  W. Copeland,et al.  Modulation of the W748S mutation in DNA polymerase gamma by the E1143G polymorphismin mitochondrial disorders. , 2006, Human molecular genetics.

[42]  K. Eckert,et al.  DNA Polymerases and Human Diseases , 2006, Radiation research.

[43]  Robert W. Taylor,et al.  Phenotypic spectrum associated with mutations of the mitochondrial polymerase γ gene. Commentary , 2006 .

[44]  Robert W. Taylor,et al.  Mutant POLG2 Disrupts DNA Polymerase γ Subunits and Causes Progressive External Ophthalmoplegia , 2006 .

[45]  W. Copeland,et al.  DNA Polymerase γ in Mitochondrial DNA Replication and Repair , 2006 .

[46]  W. Copeland,et al.  DNA polymerase gamma in mitochondrial DNA replication and repair. , 2006, Chemical reviews.

[47]  W. Copeland,et al.  Modulation of the W748S mutation in DNA polymerase γ by the E1143G polymorphism in mitochondrial disorders , 2006 .

[48]  B. Bornstein,et al.  Association of novel POLG mutations and multiple mitochondrial DNA deletions with variable clinical phenotypes in a Spanish population. , 2006, Archives of neurology.

[49]  W. Copeland,et al.  The Common A467T Mutation in the Human Mitochondrial DNA Polymerase (POLG) Compromises Catalytic Efficiency and Interaction with the Accessory Subunit* , 2005, Journal of Biological Chemistry.

[50]  W. Copeland,et al.  Consequences of mutations in human DNA polymerase γ , 2005 .

[51]  E. Holme,et al.  Low frequency of mtDNA point mutations in patients with PEO associated with POLG1 mutations , 2005, European Journal of Human Genetics.

[52]  M. Zeviani,et al.  Infantile hepatocerebral syndromes associated with mutations in the mitochondrial DNA polymerase-gammaA. , 2005, Brain : a journal of neurology.

[53]  M. Zeviani,et al.  Sequence analysis of familial PEO shows additional mutations associated with the 752C→T and 3527C→T changes in the POLG1 gene , 2004, Annals of neurology.

[54]  M. Zeviani,et al.  Structure-function defects of human mitochondrial DNA polymerase in autosomal dominant progressive external ophthalmoplegia , 2004, Nature Structural &Molecular Biology.

[55]  L. Kaguni DNA Polymerase γ, The Mitochondrial Replicase1 , 2004 .

[56]  T. Kunkel,et al.  Functions of DNA polymerases. , 2004, Advances in protein chemistry.

[57]  N. Bresolin,et al.  POLG mutations in sporadic mitochondrial disorders with multiple mtDNA deletions , 2003, Human mutation.

[58]  N. Bresolin,et al.  Remarkable infidelity of polymerase γA associated with mutations in POLG1 exonuclease domain , 2003, Neurology.

[59]  S. Dimauro,et al.  Clinical and genetic heterogeneity in progressive external ophthalmoplegia due to mutations in polymerase gamma. , 2003, Archives of neurology.

[60]  C. Broeckhoven,et al.  Novel POLG mutations in progressive external ophthalmoplegia mimicking mitochondrial neurogastrointestinal encephalomyopathy , 2003, European Journal of Human Genetics.

[61]  W. Copeland,et al.  Structural determinants in human DNA polymerase gamma account for mitochondrial toxicity from nucleoside analogs. , 2003, Journal of molecular biology.

[62]  D. Turnbull,et al.  Mutations of ANT1, Twinkle, and POLG1 in sporadic progressive external ophthalmoplegia (PEO) , 2003, Neurology.

[63]  V. Tiranti,et al.  Mutations of mitochondrial DNA polymerase γA are a frequent cause of autosomal dominant or recessive progressive external ophthalmoplegia , 2002, Annals of neurology.

[64]  W. Copeland,et al.  Differential Incorporation and Removal of Antiviral Deoxynucleotides by Human DNA Polymerase γ* , 2001, The Journal of Biological Chemistry.

[65]  Y. Tsai,et al.  Human mitochondrial DNA polymerase holoenzyme: reconstitution and characterization. , 2000, Biochemistry.

[66]  W. Copeland,et al.  The Mitochondrial p55 Accessory Subunit of Human DNA Polymerase γ Enhances DNA Binding, Promotes Processive DNA Synthesis, and Confers N-Ethylmaleimide Resistance* , 1999, The Journal of Biological Chemistry.

[67]  W. Copeland,et al.  Characterization of the native and recombinant catalytic subunit of human DNA polymerase gamma: identification of residues critical for exonuclease activity and dideoxynucleotide sensitivity. , 1998, Biochemistry.

[68]  M. Castroviejo,et al.  A second DNA polymerase activity in yeast mitochondria. , 1997, Comptes rendus de l'Academie des sciences. Serie III, Sciences de la vie.

[69]  William C. Copeland,et al.  Cloning and characterization of the human mitochondrial DNA polymerase, DNA polymerase γ , 1996 .

[70]  M. Longley,et al.  Properties of the 3' to 5' exonuclease associated with porcine liver DNA polymerase gamma. Substrate specificity, product analysis, inhibition, and kinetics of terminal excision. , 1991, The Journal of biological chemistry.

[71]  J. Lee,et al.  Application of fluorescence energy transfer and polarization to monitor Escherichia coli cAMP receptor protein and lac promoter interaction. , 1990, Proceedings of the National Academy of Sciences of the United States of America.